Aims and Scope of ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters is a peer-reviewed academic journal in the field of medicinal chemistry. Founded in 2009, this online journal is published monthly by the American Chemical Society. The Editor-in-Chief is Dennis C. Liotta (Emory University, Atlanta, Georgia, USA). Less
Key Metrics
CiteScore 

6.6
Eigenfactor 

0.01 - 0.05
Impact Factor 

< 5
SJR 

Q2Biochemistry

SNIP 

0.93
Recommended pre-submission checks
Powered by 

Topics Covered on ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | AMER CHEMICAL SOC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in ACS Medicinal Chemistry Letters ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in ACS Medicinal Chemistry Letters
Perspectives of Patents in Academic and Industrial Collaborations in Drug Discovery
- 29 Dec 2025
- ACS Medicinal Chemistry Letters
Novel Imidazopyridazine Compounds as IL-17 Inhibitors for Treating Inflammatory Diseases
- 28 Dec 2025
- ACS Medicinal Chemistry Letters
Probing the Chemical Space of Polymerase Theta with Nucleotide Analogues Bearing a Stereogenic All-Carbon Quaternary Center
- 24 Dec 2025
- ACS Medicinal Chemistry Letters
Selective 7-Azaindole Modulators Targeting Fyn and GSK-3β for Dual-Target Neuromodulation
- 24 Dec 2025
- ACS Medicinal Chemistry Letters
First-in-Class Potent, Dual HDAC6/Proteasome Inhibitors Lacking a Hydroxamic Acid Motif: Discovery of Novel Anti-Multiple Myeloma Agents
- 22 Dec 2025
- ACS Medicinal Chemistry Letters
Improving Anticancer Activity of Doxorubicin by 4′- <i>epi</i> -Dehydroxyamination
- 22 Dec 2025
- ACS Medicinal Chemistry Letters
Perspectives of Patents in Academic and Industrial Collaborations in Drug Discovery
- 29 Dec 2025
- ACS Medicinal Chemistry Letters
Novel Imidazopyridazine Compounds as IL-17 Inhibitors for Treating Inflammatory Diseases
- 28 Dec 2025
- ACS Medicinal Chemistry Letters
Probing the Chemical Space of Polymerase Theta with Nucleotide Analogues Bearing a Stereogenic All-Carbon Quaternary Center
- 24 Dec 2025
- ACS Medicinal Chemistry Letters
Selective 7-Azaindole Modulators Targeting Fyn and GSK-3β for Dual-Target Neuromodulation
- 24 Dec 2025
- ACS Medicinal Chemistry Letters
First-in-Class Potent, Dual HDAC6/Proteasome Inhibitors Lacking a Hydroxamic Acid Motif: Discovery of Novel Anti-Multiple Myeloma Agents
- 22 Dec 2025
- ACS Medicinal Chemistry Letters
Improving Anticancer Activity of Doxorubicin by 4′- <i>epi</i> -Dehydroxyamination
- 22 Dec 2025
- ACS Medicinal Chemistry Letters